Yi Xiao - Concepedia

Author

Yi Xiao

Vanderbilt University ORCID

Also Known As

Bertucci, François, Xiao, Xiao Y, Y Xiao, Y. Xiao, Yi Qun Xiao, Yi Xiao, Yilin Xiao, Youmei Xiao, YuQin Xiao

120

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Fudan University Shanghai Cancer Center The University of Texas Health Science Center at San Antonio Max Planck Institute for Molecular Genetics Freie Universität Berlin

About

Yi Xiao is an author at Vanderbilt University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.5K
2	Health Sciences	4	4	1.3K
3	Biochemistry	4	4	269
4	Natural Sciences	1	1	184
5	Public Health	1	1	73

Yi Xiao

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies Yi-Zhou Jiang, Ding Ma, Chen Suo, Cancer Cell Transcriptomic LandscapeTreatment StrategiesBreast OncologyTriple-negative Breast CancersTumor Heterogeneity	2019	1K
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy Fan Yang, Yi Xiao, Jia-Han Ding, Cell Metabolism	2022	527
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial Yi-Zhou Jiang, Yin Liu, Yi Xiao, Cell Research	2020	298
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone Nicola Di Gaetano, Yi Xiao, Eugenio Erba, British Journal of Haematology	2001	199
Cyp27c1 Red-Shifts the Spectral Sensitivity of Photoreceptors by Converting Vitamin A1 into A2 Jennifer M. Enright, Matthew B. Toomey, Shinya Sato, Current Biology Photoreceptor CellBiochemistryPhotochemistryNatural SciencesVitamin A1	2015	184
Cerebrospinal Fluid Concentrations of Gefitinib in Patients With Lung Adenocarcinoma Jing Zhao, Minjiang Chen, Wei Zhong, Clinical Lung Cancer MedicineCerebrospinal FluidLung AdenocarcinomaPathologyOncology	2012	120
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma Diana D. Shi, Milan R. Savani, Michael M. Levitt, Cancer Cell GliomaTumor HeterogeneityOncogenic AgentMolecular BiologyIdh Mutant Glioma	2022	114
Establishment of patient-derived organoid models of lower-grade glioma Kalil G. Abdullah, Cylaina Bird, Joseph Buehler, Neuro-Oncology	2021	89
Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target Dongming Chen, Wei Chen, Yong Xu, Journal of Medical Genetics	2018	73
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities Yi‐Zhou Jiang, Ding Ma, Xi Jin, Nature Cancer Breast OncologyOncologyMultiomic ProfilingTumor HeterogeneityMedicine	2024	73

Page 1